Winthrop P. Rockefeller Cancer Institute
March 25, 2024
Manojna Konda, M.D., and Vivek Yadala, M.D., Join UAMS Baptist Health Cancer Network
Oncologists Manojna Konda, M.D., and Vivek Yadala, M.D., have joined the University of Arkansas for Medical Sciences (UAMS) to support the expansion of UAMS cancer services to Baptist Health locations. Konda is a medical oncologist treating patients at the UAMS Baptist Health Cancer Center at Baptist Health Medical Center in Little Rock. She is a…
March 18, 2024
UAMS Gastrointestinal Cancer Experts Share Perspectives at 24th C.W. Rasco Symposium
About 150 physicians, nurses and researchers gathered Friday, March 8 at the UAMS Winthrop P. Rockefeller Cancer Institute for the 24th C.W. Rasco Symposium on gastrointestinal (GI) malignancies. The in-person event showcased some of the latest information on GI cancer screening, detection, treatment and research. Rangaswamy Govindarajan, M.D., chief of the UAMS Division of Hematology…
March 8, 2024
UAMS Hosts National Proteomics Symposium
Experts in proteomics, the analysis of disease-causing proteins, gathered Feb. 20 and 21 at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute for a symposium. Hosted by the IDeA National Resource for Quantitative Proteomics in the UAMS Winthrop P. Rockefeller Cancer Institute, the two-day event drew proteomics directors and staff…
March 6, 2024
UAMS Hematology Oncology Fellowship Applications Hit All-Time High
Applications to the UAMS Hematology Oncology Fellowship Program increased for the sixth consecutive year, hitting an all-time high of 371 applications for five coveted first-year spots. “It’s quite competitive,” said Kostas Arnaoutakis, M.D., UAMS thoracic medical oncologist and director of the fellowship program for the past three years. “All of the applicants are very qualified…
February 23, 2024
UAMS Myeloma Patient Grateful for ‘Life Changing’ Treatment
Jim Schepers remembers getting a call he didn’t want in April 2020. The call was from Frits van Rhee, M.D., Ph.D., clinical director of the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) and Schepers’ physician — cancer had returned. “When we found out the cancer was back, Dr. van Rhee called…
February 1, 2024
UAMS Winthrop P. Rockefeller Cancer Institute Achieves $30 Million Fundraising Goal for NCI Designation
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) met its $30 million fundraising goal for the Winthrop P. Rockefeller Cancer Institute’s campaign to achieve National Cancer Institute (NCI) Designation. The fundraising milestone was achieved with a $5 million gift from the Chris Fowler family of Jonesboro. In total, 8,700 philanthropic gifts have…
January 19, 2024
Arkansan Sees Advanced Cancer Disappear with Experimental Drug Offered at UAMS Winthrop P. Rockefeller Cancer Institute
A Little Rock man with resistant kidney cancer who underwent experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has experienced a complete remission.
January 18, 2024
UAMS Winthrop P. Rockefeller Cancer Institute to Hold Health Fair in Huntsville on Feb. 9
The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute will host a free public health fair at the Madison County Public Library in Huntsville on Feb. 9. The event will run from 10 a.m. to 1 p.m. at the library, located at 827 N. College St. Patient navigators from the UAMS…
December 15, 2023
Behind the Scenes
Yan Cheng, Ph.D. Yan Cheng, Ph.D., is an instructor for the UAMS Winthrop P. Rockefeller Cancer Institute’s Myeloma Center. Cheng, who joined the Myeloma Center team in 2021, conducts translational research, including identifying the biology of multiple myeloma risk genes. Her research focuses on unravelling the mechanisms of resistance to therapy to help develop new…
Publications
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level Blood Advances November 2022 Primary author: Carolina Schinke, M.D. Multiple myeloma (MM) is preceded by precursor stages including MGUS and smoldering myeloma. It is thought that the acquisition of mutations in the myeloma cells is responsible for disease progression through these…
Previous page Next page